Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. News
  7. Summary
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 11/30 09:36:50 am
165.42 USD   +0.07%
11/24SEAGEN : Material Event - Form 8-K
PU
11/24SEAGEN INC. : Other Events (form 8-K)
AQ
11/19Seagen to Highlight New Data in Advanced Breast Cancer at 2021 San Antonio Breast Cancer Symposium
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Seagen : Astellas Complete Enrollment in Cohort K of Study of Padcev, Keytruda Combination to Treat Urothelial Cancer

10/12/2021 | 09:53am EST


ę MT Newswires 2021
All news about SEAGEN INC.
11/24SEAGEN : Material Event - Form 8-K
PU
11/24SEAGEN INC. : Other Events (form 8-K)
AQ
11/19Seagen to Highlight New Data in Advanced Breast Cancer at 2021 San Antonio Breast Cance..
BU
11/19Seagen to Highlight New Data in Advanced Breast Cancer at 2021 San Antonio Breast Cance..
CI
11/15INSIDER SELL : Seagen
MT
11/09Wolfe Research Starts Seagen at Peer Perform With $195 Price Target
MT
11/09Seagen to Highlight Two Novel Antibody-Drug Conjugates (ADCs) at the SITC 36th Annual M..
BU
11/09Seagen to Highlight Two Novel Antibody-Drug Conjugates at the SITC 36th Annual Meeting
CI
11/08INSIDER SELL : Seagen
MT
11/04Seagen to Highlight Multiple ADCETRIS« (brentuximab vedotin) Data Presentations at the ..
BU
More news
Analyst Recommendations on SEAGEN INC.
More recommendations
Financials (USD)
Sales 2021 1 549 M - -
Net income 2021 -647 M - -
Net cash 2021 2 361 M - -
P/E ratio 2021 -46,3x
Yield 2021 -
Capitalization 30 228 M 30 228 M -
EV / Sales 2021 18,0x
EV / Sales 2022 12,8x
Nbr of Employees 2 092
Free-Float 99,3%
Chart SEAGEN INC.
Duration : Period :
Seagen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEAGEN INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 165,31 $
Average target price 190,05 $
Spread / Average Target 15,0%
EPS Revisions
Managers and Directors
Clay B. Siegall Chairman, President & Chief Executive Officer
Todd E. Simpson Chief Financial Officer
Vaughn B. Himes Chief Technical Officer
Roger D. Dansey Chief Medical Officer
Marc E. Lippman Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEAGEN INC.-5.61%30 228
MODERNA, INC.252.74%149 412
LONZA GROUP AG28.41%58 671
IQVIA HOLDINGS INC.48.85%50 948
CELLTRION, INC.-40.81%24 321
ICON PUBLIC LIMITED COMPANY41.59%22 472